Liquid biopsy is a simple blood test that offers a convenient, non-invasive option for early detection of colorectal cancer screening in Abu Dhabi, not replacing colonoscopy which is the gold standard of screening.
While liquid biopsy is now new FDA-approved method for colorectal cancer screening, it enhances rather than replaces colonoscopy, the gold standard for diagnosis.
This type of tests will enforce Abu Dhabi efforts toward the early detection of cancer.
This innovative test could revolutionize how Abu Dhabi detects early stage of colorectal cancer.
Abu Dhabi is taking the lead with its IFHAS program, implementing the new liquid biopsy technology at scale.
Together, we're making strides toward early colorectal cancer detection and improving patient outcomes.